- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/03 - Peptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof
Patent holdings for IPC class A61K 38/03
Total number of patents in this class: 552
10-year publication summary
|
46
|
43
|
55
|
42
|
31
|
55
|
35
|
31
|
29
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20802 |
14 |
| Realta Holdings, LLC | 29 |
9 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3267 |
7 |
| University of Washington | 2451 |
7 |
| Thetis Pharmaceuticals LLC | 23 |
6 |
| Xigen SA | 14 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6678 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
5 |
| Regeneron Pharmaceuticals, Inc. | 4780 |
5 |
| Universite de Strasbourg | 709 |
5 |
| Limited Liability Company "mitotechnology" | 8 |
5 |
| Wisconsin Alumni Research Foundation | 3901 |
4 |
| Cornell Research Foundation, Inc. | 172 |
4 |
| Cornell University | 3438 |
4 |
| Ohio State Innovation Foundation | 2383 |
4 |
| R.P. Scherer Technologies, LLC | 338 |
4 |
| The University of Melbourne | 569 |
4 |
| Xigen Inflammation Ltd. | 24 |
4 |
| The Board of Regents of the University of Texas System | 2304 |
4 |
| Centre National de La Recherche Scientifique | 11055 |
3 |
| Other owners | 443 |